Departments of Neurology; Stroke Centre, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
Neurol India. 2012 Jul-Aug;60(4):373-8. doi: 10.4103/0028-3886.100719.
Elderly patients with major ischemic strokes may remain severely disabled or dead. However, efficacy and safety of thrombolysis in this have not been fully explored.
Data from the case records of patients aged >80 years with acute ischemic stroke with admission National Institute of Health Stroke Scale (NIHSS) score ≥10 admitted between April 2009 and May 2011 were retrieved. Outcomes in patients treated with thrombolysis and control subjects were compared. Primary outcome was 3-month modified Rankin Scale (mRS) score 0-2. Secondary outcomes were 3-month mRS score 0-3, mRS score 5-6, mortality, and improvement NIHHS score at discharge. Safety outcome was hemorrhagic transformation.
Study subjects included 22 patients treated with thrombolysis and 23 controls not treated with thrombolysis. Age, stroke severity, and proportion of identified major vessel occlusions were the variables for comparison between the two groups. More patients in the thrombolyzed group had mRS 0-2 outcome than in non-thrombolyzed group (18.2% vs. 0%; P = 0.049). Proportion of patients with mRS 0-3 outcome was also higher in thrombolyzed group than in non-thrombolyzed group (22.7% vs. 0%; P = 0.022). Patients in the thrombolyzed group had higher mortality, non-significant when compared to patients in the non-thrombolyzed group (18.2% vs. 8.7%; P = 0.414). However, lesser number of patients in the thrombolyzed group had mRS 5-6 outcome (35% vs. 65%; P = 0.075). Median improvement in NIHSS score at discharge also showed a more favorable trend in thrombolyzed group (10 vs. 2; P = 0.082). Rates of symptomatic and asymptomatic hemorrhagic transformations in thrombolyzed group were 4.5% and 27.3% respectively.
For elderly patients with major ischemic strokes, thrombolysis offers a greater chance of functional independence.
患有大梗死性脑卒中的老年患者可能会遗留严重残疾或死亡。然而,溶栓治疗在这方面的疗效和安全性尚未得到充分探索。
检索了 2009 年 4 月至 2011 年 5 月期间因急性缺血性脑卒中入院,入院时国立卫生研究院卒中量表(NIHSS)评分≥10 分且年龄>80 岁的患者的病历数据。比较溶栓治疗组和对照组患者的结局。主要结局为 3 个月时改良 Rankin 量表(mRS)评分 0-2。次要结局为 3 个月时 mRS 评分 0-3、mRS 评分 5-6、死亡率和出院时 NIHHS 评分改善。安全性结局为出血性转化。
研究对象包括 22 例溶栓治疗患者和 23 例未溶栓治疗对照组患者。年龄、卒中严重程度和确定的大血管闭塞比例是两组比较的变量。溶栓组 mRS 0-2 结局的患者比例高于非溶栓组(18.2%比 0%;P=0.049)。溶栓组 mRS 0-3 结局的患者比例也高于非溶栓组(22.7%比 0%;P=0.022)。溶栓组死亡率较高,但与非溶栓组相比无统计学意义(18.2%比 8.7%;P=0.414)。然而,溶栓组 mRS 5-6 结局的患者比例较低(35%比 65%;P=0.075)。出院时 NIHSS 评分的中位数改善也显示出溶栓组更有利的趋势(10 分比 2 分;P=0.082)。溶栓组症状性和无症状性出血性转化的发生率分别为 4.5%和 27.3%。
对于患有大梗死性脑卒中的老年患者,溶栓治疗可提高其功能独立性的机会。